When more is just more, not better: a recurring lesson

por Smith, Sonali M.
Publicado 2023

Too much and not enough: revisiting maintenance rituximab in indolent lymphomas

por Smith, Sonali M.
Publicado 2021

Indolent lymphomas: introduction to a series highlighting progress and ongoing challenges

por Smith, Sonali M., Salles, Gilles
Publicado 2022

Evolution of therapy for limited stage diffuse large B-cell lymphoma

por Rojek, Alexandra E., Smith, Sonali M.
Publicado 2022

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib

por Guo, Ailin, Lu, Pin, Galanina, Natalie, Nabhan, Chadi, Smith, Sonali M., Coleman, Morton, Wang, Y. Lynn
Publicado 2015

Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma

por Chiu, Brian C.-H., Chen, Chang, You, Qiancheng, Chiu, Rudyard, Venkataraman, Girish, Zeng, Chang, Zhang, Zhou, Cui, Xiaolong, Smith, Sonali M., He, Chuan, Zhang, Wei
Publicado 2021

Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma

por Yamshon, Samuel, Chen, Gui Zhen, Gribbin, Caitlin, Christos, Paul, Shah, Bijal, Schuster, Stephen J., Smith, Sonali M., Svoboda, Jakub, Furman, Richard R., Leonard, John P., Martin, Peter, Ruan, Jia
Publicado 2023

Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

por Stephens, Deborah M., Li, Hongli, Constine, Louis S., Fitzgerald, Thomas J., Leonard, John P., Kahl, Brad S., Song, Joo Y., LeBlanc, Michael L., Smith, Sonali M., Persky, Daniel O., Friedberg, Jonathan W.
Publicado 2022

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma

por Burack, W. Richard, Li, Hongli, Adlowitz, Diana, Spence, Janice M., Rimsza, Lisa M., Shadman, Mazyar, Spier, Catherine M., Kaminski, Mark S., Leonard, John P., Leblanc, Michael L., Smith, Sonali M., Friedberg, Jonathan W.
Publicado 2023

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation

por Godfrey, James, Liu, Hongtao, Yu, Jovian, Tallarico, Michael, Curran, Emily, Artz, Andrew, Riedell, Peter A., Stock, Wendy, Karrison, Theodore, Fitzpatrick, Carrie, Venkataraman, Girish, Cooper, Alan, Smith, Sonali M., Bishop, Michael R., Kline, Justin
Publicado 2022

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

por Martin, Peter, Bartlett, Nancy L., Chavez, Julio C., Reagan, John L., Smith, Sonali M., LaCasce, Ann S., Jones, Jeffrey, Drew, James, Wu, Chengqing, Mulvey, Erin, Revuelta, Maria V., Cerchietti, Leandro, Leonard, John P.
Publicado 2022

Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas

por Major, Ajay, Kline, Justin, Karrison, Theodore G., Fishkin, Paul A. S., Kimball, Amy S., Petrich, Adam M., Nattam, Sreenivasa, Rao, Krishna, Sleckman, Bethany G., Cohen, Kenneth, van Besien, Koen, Rapoport, Aaron P., Smith, Sonali M.
Publicado 2021

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

por Epperla, Narendranath, Ahn, Kwang Woo, Ahmed, Sairah, Jagasia, Madan, DiGilio, Alyssa, Devine, Steven M., Jaglowski, Samantha, Kennedy, Vanessa, Rezvani, Andrew R., Smith, Sonali M., Sureda, Anna, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Armand, Phillipe, Hamadani, Mehdi
Publicado 2017

TIGIT is a key inhibitory checkpoint receptor in lymphoma

por Godfrey, James, Chen, Xiufen, Sunseri, Nicole, Cooper, Alan, Yu, Jovian, Varlamova, Arina, Zarubin, Dmitry, Popov, Yuriy, Jacobson, Connor, Postovalova, Ekaterina, Xiang, Zhongmin, Nomie, Krystle, Bagaev, Aleksander, Venkataraman, Girish, Zha, Yuanyuan, Tumuluru, Sravya, Smith, Sonali M, Kline, Justin P
Publicado 2023

Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration

por Stephens, Deborah M., Boucher, Ken, Kander, Elizabeth, Parikh, Sameer A., Parry, Erin M., Shadman, Mazyar, Pagel, John M., Cooperrider, Jennifer, Rhodes, Joanna, Mato, Anthony, Winter, Allison, Hill, Brian, Gaballa, Sameh, Danilov, Alexey, Phillips, Tycel, Brander, Danielle M., Smith, Sonali M., Davids, Matthew S., Rogers, Kerry, Glenn, Martha J., Byrd, John C.
Publicado 2020

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

por Salles, Gilles, Schuster, Stephen J., Dreyling, Martin, Fischer, Luca, Kuruvilla, John, Patten, Piers E.M., von Tresckow, Bastian, Smith, Sonali M., Jiménez-Ubieto, Ana, Davis, Keith L., Anjos, Carla, Chu, Jufen, Zhang, Jie, Lobetti Bodoni, Chiara, Thieblemont, Catherine, Fowler, Nathan H., Dickinson, Michael, Martínez-López, Joaquin, Wang, Yucai, Link, Brian K.
Publicado 2022

Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network

por Federico, Massimo, Bellei, Monica, Marcheselli, Luigi, Schwartz, Marc, Manni, Martina, Tarantino, Vittoria, Pileri, Stefano, Ko, Young‐Hyeh, Cabrera, Maria E., Horwitz, Steven, Kim, Won S., Shustov, Andrei, Foss, Francine M., Nagler, Arnon, Carson, Kenneth, Pinter‐Brown, Lauren C., Montoto, Silvia, Spina, Michele, Feldman, Tatyana A., Lechowicz, Mary J., Smith, Sonali M., Lansigan, Frederick, Gabus, Raul, Vose, Julie M., Advani, Ranjana H.
Publicado 2018

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma

por Klyuchnikov, Evgeny, Bacher, Ulrike, Ahn, Kwang Woo, Carreras, Jeanette, Kröger, Nicolaus M., Hari, Parameswaran N., Ku, Grace H., Ayala, Ernesto, Chen, Andy I., Chen, Yi-Bin, Cohen, Jonathon B., Freytes, César O., Gale, Robert Peter, Kamble, Rammurti T., Kharfan-Dabaja, Mohamed A., Lazarus, Hillard M., Martino, Rodrigo, Mussetti, Alberto, Savani, Bipin N., Schouten, Harry C., Usmani, Saad Z., Wiernik, Peter H., Wirk, Baldeep, Smith, Sonali M., Sureda, Anna, Hamadani, Mehdi
Publicado 2015

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

por Bachanova, Veronika, Burns, Linda J., Wang, Tao, Carreras, Jeanette, Gale, Robert Peter, Wiernik, Peter H., Ballen, Karen K., Wirk, Baldeep, Munker, Reinhold, Rizzieri, David A., Chen, Yi-Bin, Gibson, John, Akpek, Görgün, Costa, Luciano J., Kamble, Rammurti T., Aljurf, Mahmoud D., Hsu, Jack W., Cairo, Mitchell S., Schouten, Harry C., Bacher, Ulrike, Savani, Bipin N., Wingard, John R., Lazarus, Hillard M., Laport, Ginna G., Montoto, Silvia, Maloney, David G., Smith, Sonali M., Brunstein, Claudio, Saber, Wael
Publicado 2014

American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Cl...

por Munshi, Pashna N., Hamadani, Mehdi, Kumar, Ambuj, Dreger, Peter, Friedberg, Jonathan W., Dreyling, Martin, Kahl, Brad, Jerkeman, Mats, Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Shadman, Mazyar, Hill, Brian T., Ahmed, Sairah, Herrera, Alex F., Sauter, Craig S., Bachanova, Veronika, Ghosh, Nilanjan, Lunning, Matthew, Kenkre, Vaishalee P., Aljurf, Mahmoud, Wang, Michael, Maddocks, Kami J., Leonard, John P., Kamdar, Manali, Phillips, Tycel, Cashen, Amanda F., Inwards, David J., Sureda, Anna, Cohen, Jonathon B., Smith, Sonali M., Carlo-Stella, Carmello, Savani, Bipin, Robinson, Stephen P., Fenske, Timothy S.
Publicado 2021